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Placental cadherin (P-cadherin) is a classical cadherin
[1] expressed by myoepithelial cells of the human mam-
mary gland [2,3]. Changes to P-cadherin expression
have been observed and implicated in human breast car-
cinogenesis [4-6]. Feline mammary tumours show simi-
larities with the women tumours concerning many
histological characteristics and clinical evolution, being
proposed as good animal model to study mammary car-
cinogenesis [7].
To study P-cadherin expression in feline mammary
gland an immunohistochemistry assay was performed in
61 samples of normal (n = 4), hyperplastic (n = 12),
benign (n = 6) and malignant (n = 39) feline mammary
tissues and the immunostaining assessment was based
on the estimated percentage of luminal epithelial cells
labeling (aberrant expression).
In normal mammary gland, mammary hyperplasia and
benign tumours, P-cadherin immunolabelling was
restricted to myoepithelial cells. Nevertheless, in malig-
nant tumours there was an aberrant epithelial P-
cadherin immunoexpression in 64,1% (n = 25) of the
cases, with a membranar and/or cytoplasmic pattern of
cellular distribution. Consequently, P-cadherin expres-
sion in feline mammary lesions was not exclusive of
myoepithelial cells.
It was possible to observe a significant statistical cor-
relation between P-cadherin expression intensity and
feline mammary lesions (p = 0.0001). In malignant
mammary tumors a statistical correlation between
P-cadherin immunoexpression intensity and histological
grade was observed (p = 0.0132). Aberrant epithelial
P-cadherin expression seems to be correlated with
tumor malignancy in feline mammary gland.
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